Online citations, reference lists, and bibliographies.

Hodgkin And Non-Hodgkin Lymphoma

F. Moog
Published 2000 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The incidence of malignant lymphomas stands at about five new cases per 100 000 persons per year. These include instances both of Hodgkin’s disease (HD) and the heterogeneous group of non-Hodgkin lymphomas (NHL), with a relative frequency of about 1:3. Lymphomas originate from cells of the pul-pal tissue of the lymph nodes. Hodgkin’s lymphomas are characterized by a very small proportion of specific tumor cells (Hodgkin cells, Reed-Sternberg giant cells) surrounded by numerous nonneoplastic cells. This is distinct from the histological picture of NHL, whose pathognomonic cells constitute the main mass of the tumor.
This paper references
10.1148/radiology.135.1.6892659
Non-Hodgkin lymphoma of bone.
E. Braunstein (1980)
Radiologic concepts of lymphoma of bone.
B. Edeiken-Monroe (1990)
10.1182/BLOOD.V91.9.3340.3340_3340_3346
Detection of lymphoma in bone marrow by whole-body positron emission tomography.
R. Carr (1998)
10.1111/J.1445-5994.1999.TB01581.X
Antipseudomonal antibiotics and cystic fibrosis.
R. Henry (1999)
10.3109/10428199909058482
Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease.
E. Wiedmann (1999)
10.1200/JCO.1989.7.1.81
Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease.
M. Leibenhaut (1989)
10.1148/radiology.190.1.8259386
Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
J. Newman (1994)
10.1200/JCO.1987.5.2.225
The detection of bone marrow involvement by lymphoma using magnetic resonance imaging.
A. Shields (1987)
10.2214/ajr.152.1.175
The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide.
R. Weissleder (1989)
[Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].
R. Thill (1997)
Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.
J. Braams (1995)
10.1007/s001170050179
Positron emission tomography (PET) for diagnosis and therapy management of malignant lymphomas
A. Dimitrakopoulou-Strauss (1997)
10.1016/0720-048X(91)90103-3
Magnetic resonance imaging in the initial staging of Hodgkin's disease and non-Hodgkin lymphoma.
J. D. Tesoro-Tess (1991)
10.1148/radiology.188.2.8327702
Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
E. Patz (1993)
Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
M. Rodríguez (1998)
FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.
F. Moog (1999)
10.7326/0003-4819-76-2-219
Liver biopsy in Hodgkin's disease. Clinicopathologic correlations in 127 patients.
C. Bagley (1972)
PET scanning and the human immunodeficiency virus-positive patient.
M. O'Doherty (1997)
10.1016/0277-5379(82)90110-9
The liver in Hodgkin's disease--II. Histopathologic findings.
T. Skovsgaard (1982)
10.1182/BLOOD.V91.12.4464
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose.
W. Römer (1998)
10.1148/radiology.189.3.8234714
Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.
K. Zasadny (1993)
Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.
R. Kubota (1992)
10.1136/thx.50.12.1267
Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes.
T. Arita (1995)
10.1055/S-2007-1015162
Computertomographie und F-18-FDG-Positronen-Emissions-Tomographie im Staging maligner Lymphome: ein Vergleich
D. Bumann (1998)
[Positron-emission tomography in the diagnosis of abdominal tumors].
S. Reske (1998)
10.1148/radiology.160.3.3737899
Hodgkin disease: contributions of chest CT in the initial staging evaluation.
R. Castellino (1986)
10.1111/j.1445-5994.1994.tb04417.x
The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
G. Larcos (1994)
10.1148/radiographics.11.4.1887120
CT of lymphoma: spectrum of disease.
E. K. Fishman (1991)
Imaging techniques for staging abdominal Hodgkin's disease.
Castellino Ra (1982)
10.1093/annonc/3.suppl_4.S45
Diagnostic imaging studies in patients with newly diagnosed Hodgkin's disease.
R. Castellino (1992)
10.1016/S0140-6736(96)91416-6
Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography
I. Taylor (1996)
10.1055/s-2007-1015764
Vortäuschung eines mediastinalen Non-Hodgkin-Lymphomrezidivs durch diffuse Thymushyperplasie im 18F-FDG-PET
S. Glatz (1996)
10.1007/BF00257539
Bone marrow investigation with technetium-99m microcolloid and magnetic resonance imaging in patients with malignant myelolympho-proliferative diseases
A. Widding (1989)
10.1002/ajh.2830030201
Frequencies and patterns of bone marrow involvement in non‐hodgkin lymphomas: Observations on the value of bilateral biopsies
B. Coller (1977)
10.1007/978-3-642-80829-6_19
Staging laparotomy and splenectomy in Hodgkin's disease: analysis of indications and patterns of involvement in 285 consecutive, unselected patients.
H. Kaplan (1973)
Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.
S. Leskinen-Kallio (1991)
10.1148/radiology.166.1.3336704
Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance.
B. Gross (1988)
10.1055/s-2008-1048374
Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
L. Jánoskúti (1988)
10.1148/RADIOLOGY.206.2.9457202
Extranodal malignant lymphoma: detection with FDG PET versus CT.
F. Moog (1998)
10.1002/1097-0142(19910401)67:7<1838::AID-CNCR2820670704>3.0.CO;2-O
A prospective study of magnetic resonance imaging in lymphoma staging
J. Skillings (1991)
Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.
V. Lowe (1994)
10.2214/ajr.138.2.229
Importance of initial mediastinal adenopathy in Hodgkin disease.
L. North (1982)
Knochenszintigraphie und Radiographie bei der Beurteilung von Patienten, die an malignem Lymphom erkrankt sind
L. Jánoskuti (1988)
Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy.
O. Hoekstra (1993)
Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.
D. N. Jones (1996)
10.1002/1097-0142(19951015)76:8<1460::AID-CNCR2820760825>3.0.CO;2-Y
Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Verification by laparotomy in 100 cases
R. Munker (1995)
10.1080/028418699432969
Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest.
M. Bangerter (1999)
10.1016/0959-8049(92)90243-U
Tumour burden as the main indicator of prognosis in Hodgkin's disease.
L. Specht (1992)
10.1055/s-2007-998651
Histologisch kontrollierter Vergleich von Palpation und Sonographie bei der Diagnose von Halslymphknotenmetastasen
T. Eichhorn (1987)
10.1148/radiology.170.1.2909090
Non-Hodgkin lymphoma: influence of lymphography, CT, and bone marrow biopsy on staging and management.
G. D. Pond (1989)
Predicting malignancy grade with PET in non-Hodgkin's lymphoma.
M. Rodríguez (1995)
10.1002/1097-0142(197609)38:3<1142::AID-CNCR2820380315>3.0.CO;2-K
Bone scanning in lymphoma
J. Schechter (1976)
10.1148/radiology.180.2.2068292
Upper abdominal lymph nodes: criteria for normal size determined with CT.
R. Dorfman (1991)
10.2214/ajr.143.1.37
Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin disease.
R. Castellino (1984)
Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
K. Higashi (1993)
10.1182/blood.V86.9.3522.bloodjournal8693522
Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose.
M. Lapela (1995)
10.1148/radiology.186.1.8416578
Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation.
B. Jabour (1993)
10.1093/annonc/8.suppl_1.S57
Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma.
M. de Wit (1997)
FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
J. Hoffman (1993)
10.1148/radiology.164.3.3112862
Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval.
L. North (1987)
10.1002/1097-0142(197505)35:5<1346::AID-CNCR2820350516>3.0.CO;2-I
Detection of skeletal involvement in Hodgkin's disease: A comparison of radiography, bone scanning, and bone marrow biopsy in 38 patients
A. Ferrant (1975)
10.1148/radiology.203.3.9169707
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
F. Moog (1997)
10.1111/j.1440-1673.1994.tb00150.x
Hodgkins disease: clinical and radiological prognostic factors in a laparotomy series.
S. Pendlebury (1994)
10.1016/s0889-8588(18)30588-4
Bone marrow in malignant lymphoma.
R. Mckenna (1988)
10.1148/radiographics.11.3.1852937
Abdominal lymphadenopathy: spectrum of CT findings.
D. Einstein (1991)
10.1200/JCO.1998.16.2.603
18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
F. Moog (1998)
10.1007/BF03165015
FDG-PET for the evaluation of tumor viability after anticancer therapy
J. Okada (1994)
10.1002/1097-0142(19901201)66:11<2295::AID-CNCR2820661107>3.0.CO;2-S
Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease: A southwest oncology group study
C. Mansfield (1990)
10.1002/1097-0142(196604)19:4<461::AID-CNCR2820190402>3.0.CO;2-X
Malignant lymphoma of the spleen. A review of 49 cases in which the diagnosis was made at splenectomy
D. Ahmann (1966)
10.1055/s-0038-1629839
Vergleich der Befunde von 18-FDG-PET und CT beim prätherapeutischen Staging maligner Lymphome
R. Thill (1997)
10.2214/ajr.150.5.1095
Lymphoma of the skeleton: scintigraphic evaluation.
J. Orzel (1988)
Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
C. Hoh (1997)
Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity.
J. Okada (1992)
10.1148/RADIOGRAPHICS.18.4.9672967
FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls.
H. Vesselle (1998)
10.1148/radiology.199.3.8638000
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
P. Shreve (1996)
10.1016/S1078-8174(99)90024-X
Role of whole body FDG-PET imaging in predicting relapse of malignant lymphoma in patients with residual masses after treatment
M. Bangerter (1999)
10.1007/s002590050356
Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma
J. Kotzerke (1999)
10.1182/blood.V78.3.728.bloodjournal783728
Detection of lymphomatous bone marrow involvement with magnetic resonance imaging.
B. R. Hoane (1991)
10.1002/ajh.2830300302
Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: Sensitivity and specificity of the ann arbor staging procedure criteria
M. E. Ellis (1989)
10.1097/00004728-199507000-00004
Differential Diagnosis of CNS Lesions in AIDS Patients by FDG‐PET
K. Villringer (1995)
10.1200/JCO.1993.11.11.2101
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.
R. Wahl (1993)
10.1200/JCO.1988.6.6.940
The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease.
J. Radford (1988)



Semantic Scholar Logo Some data provided by SemanticScholar